Comparison of the metabolic profiles and their cardiovascular event risks of metformin users versus insulin users. A cohort study of people with type 2 diabetes from the UK Biobank — Li-Ju Chen (2025) | RDL Network
Comparison of the metabolic profiles and their cardiovascular event risks of metformin users versus insulin users. A cohort study of people with type 2 diabetes from the UK Biobank
Article 2025 en
Authors
LC
Li-Ju Chen
CH
Christian Herder
RX
Ruijie Xie
Abstract
1 min read
Metformin and insulin users have different metabolic profiles and a consistent pattern emerged that the metabolic profile of metformin users is favorable compared to the one of insulin users due to a lower associated MACE risk.
Oliver Robinson, Alice R Carter, Mika Ala‐Korpela, Juan P. Casas, Nish Chaturvedi, Jorgen Engmann, Laura D Howe, Alun D. Hughes, Paul M Ridker, Mika Kähönen, Ville Karhunen, Diana Kuh, Tina Shah, Yoav Ben‐Shlomo, Reecha Sofat, Chung‐Ho E. Lau, Terho Lehtimäki, Usha Menon, Olli T. Raitakari, Andy Ryan, Rui Providência, Stephanie Smith, Julie Taylor, Therese Tillin, Jorma Viikari, Andrew Wong, Aroon D. Hingorani, Mika Kivimäki, Paolo Vineis
Khalid M. Alkharfy, Nasser M. Al‐Daghri, Shaun Sabico, Abdulaziz M. Al-Othman, Osama Moharram, Majed S. Alokail, Yousef Al‐Saleh, Sudhesh Kumar, George Chrousos
Ruifang Li‐Gao, Renée de Mutsert, Patrick C.N. Rensen, Jan B. van Klinken, Cornelia Prehn, Jerzy Adamski, Astrid van Hylckama Vlieg, Martin den Heijer, Saskia le Cessie, Frits R. Rosendaal, Ko Willems van Dijk, Dennis O. Mook‐Kanamori
Discussion(0)
No comments yet. Be the first to comment.